COMPASS Pathways plc (CMPS)
NASDAQ: CMPS · Real-Time Price · USD
5.82
+0.14 (2.46%)
At close: Dec 5, 2025, 4:00 PM EST
5.88
+0.06 (1.02%)
After-hours: Dec 5, 2025, 7:58 PM EST
COMPASS Pathways Market Cap
COMPASS Pathways has a market cap or net worth of $558.82 million as of December 5, 2025. Its market cap has increased by 71.58% in one year.
Market Cap
558.82M
Enterprise Value
408.07M
1-Year Change
71.58%
Ranking
Category
Stock Price
$5.82
Market Cap Chart
Since the IPO on September 18, 2020, COMPASS Pathways's market cap has decreased from $568.58M to $558.82M, a decrease of -1.72%. That is a compound annual growth rate of -0.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 558.82M | 116.07% |
| Dec 31, 2024 | 258.63M | -52.25% |
| Dec 29, 2023 | 541.59M | 58.41% |
| Dec 30, 2022 | 341.89M | -62.93% |
| Dec 31, 2021 | 922.26M | -46.12% |
| Dec 31, 2020 | 1.71B | 201.05% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 925.43B |
| Johnson & Johnson | 494.70B |
| AbbVie | 406.92B |
| UnitedHealth Group | 307.72B |
| AstraZeneca | 283.29B |
| Novartis AG | 257.47B |
| Merck & Co. | 253.84B |
| Thermo Fisher Scientific | 218.08B |